These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 32078435)
1. Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier Homeostasis. Yang JM; Park CS; Kim SH; Noh TW; Kim JH; Park S; Lee J; Park JR; Yoo D; Jung HH; Takase H; Shima DT; Schwaninger M; Lee S; Kim IK; Lee J; Ji YS; Jon S; Oh WY; Kim P; Uemura A; Ju YS; Kim I Circ Res; 2020 Mar; 126(6):767-783. PubMed ID: 32078435 [TBL] [Abstract][Full Text] [Related]
2. Upregulated miR-194-5p suppresses retinal microvascular endothelial cell dysfunction and mitigates the symptoms of hypertensive retinopathy in mice by targeting SOX17 and VEGF signaling. Wan Q; Liu H; Xu Y; Zhang Q; Tao L Cell Cycle; 2023 Feb; 22(3):331-346. PubMed ID: 36200131 [TBL] [Abstract][Full Text] [Related]
4. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension. Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441 [TBL] [Abstract][Full Text] [Related]
5. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074 [TBL] [Abstract][Full Text] [Related]
6. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis. Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984 [TBL] [Abstract][Full Text] [Related]
7. Dll4-Notch1 signaling but not VEGF-A is essential for hyperoxia induced vessel regression in retina. Zhu G; Lin Y; Liu H; Jiang D; Singh S; Li X; Yu Z; Fan L; Wang S; Rhen J; Li W; Xu Y; Ge J; Pang J Biochem Biophys Res Commun; 2018 Dec; 507(1-4):400-406. PubMed ID: 30448061 [TBL] [Abstract][Full Text] [Related]
13. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. Kim JH; Kim JH; Yu YS; Cho CS; Kim KW J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135 [TBL] [Abstract][Full Text] [Related]
14. Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina. Zhou Y; Williams J; Smallwood PM; Nathans J PLoS One; 2015; 10(12):e0143650. PubMed ID: 26630461 [TBL] [Abstract][Full Text] [Related]
15. Dll4 Blockade Promotes Angiogenesis in Nonhealing Wounds of Sox7-Deficient Mice. Yang JM; Ryu J; Kim I; Chang H; Kim IK Adv Wound Care (New Rochelle); 2020 Nov; 9(11):591-601. PubMed ID: 33095124 [No Abstract] [Full Text] [Related]
16. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina. Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836 [TBL] [Abstract][Full Text] [Related]
17. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L Elife; 2020 Apr; 9():. PubMed ID: 32312382 [TBL] [Abstract][Full Text] [Related]
19. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]